# Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

> **NCT00954811** · PHASE4 · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 40 (estimated)

## Conditions studied

- Pregnancy
- Pregnancy Loss

## Interventions

- **DRUG:** 300IU rec-LH
- **DRUG:** progesterone 600mg

## Key facts

- **NCT ID:** NCT00954811
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** 2008-01
- **Final completion:** 2010-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00954811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00954811, "Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00954811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*